Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 1, January, p. 101–106

doi: 10.17219/acem/112609

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Multiplex ligation-dependent probe amplification as a screening test in children with autism spectrum disorders

Izabela Łaczmańska1,A,B,C,D,E,F, Agnieszka Stembalska1,B,D,E,F, Magdalena Złocińska1,B,C, Joanna Kozłowska1,B,C, Paweł Skiba1,B,C, Karolina Pesz1,B,C,D,F, Ryszard Ślęzak1,B,C,E, Robert Śmigiel2,B,C,E, Aleksandra Jakubiak1,B,C, Błażej Misiak1,B,C,E, Maria M. Sąsiadek1,B,C,E,F

1 Department of Genetics, Wroclaw Medical University, Poland

2 Department of Pediatrics and Rare Disorders, Wroclaw Medical University, Poland


Background. Autism spectrum disorders (ASDs) are a heterogeneous group of neurodevelopmental disorders, characterized by the presence of various symptoms related to deficits in communication and social interactions as well as stereotyped and repetitive behavior. Increasing evidence indicates the contribution of genetic factors in the etiology of ASDs. Genetic diagnosis in ASDs is based on identifying chromosome aberrations, microaberrations and point mutations in specific genes. One of the diagnostic tools is multiplex ligase-dependent probe amplification (MLPA) with a set of probes dedicated to ASDs (SALSA MLPA P343 Autism-1; MRC-Holland BV, Amsterdam, the Netherlands) targeting the genes located in the regions 15q11-q13, 16p11 and the SHANK3 gene in the 22q13 region.
Objectives. Our study included 240 patients referred to the clinical genetics unit because of ASDs and/or developmental delay and/or an intellectual disability. Before genetic testing, the patients underwent a comprehensive medical work-up.
Material and Methods. Multiplex ligase-dependent probe amplification was performed in 256 DNA samples from 240 probands and 16 family members using the SALSA MLPA P343 Autism-1 probe mix (MRC-Holland BV) according to the manufacturer’s protocol.
Results. We obtained 234 normal results and 22 abnormal results (15 probands and 7 abnormal results for probands’ parents or siblings). We diagnosed 1 16p11 microdeletion syndrome and 1 16p11 microduplication syndrome. We also found 3 deletions and 1 duplication in 15q13 region including 2 or 3 genes and 9 single probe alterations in the regions examined (1 duplication and 7 deletions).
Conclusion. Due to the low costs, MLPA test may be a good tool for the genetic screening of ASD patients.

Key words

diagnostics, autism, MLPA

References (18)

  1. Bremer A, Giacobini M, Nordenskjöld M, et al. Screening for copy number alterations in loci associated with autism spectrum disorders by two-color multiplex ligation-dependent probe amplification. Am J Med Genet Part B Neuropsychiatr Genet. 2009;153B(1):280–285. doi:10.1002/ajmg.b.30954
  2. An JY, Claudianos C. Genetic heterogeneity in autism: From single gene to a pathway perspective. Neurosci Biobehav Rev. 2016;68:442−453. doi:10.1016/j.neubiorev.2016.06.013
  3. Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism spectrum disorder among children aged 8 years: Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveill Summ. 2018;67(6):1−23. doi:10.15585/mmwr.ss6706a1
  4. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: A decade of new twin studies. Am J Med Genet Part B Neuropsychiatr Genet. 2011;156(3):255−274. doi:10.1002/ajmg.b.31159
  5. Cai G, Edelmann L, Goldsmith JE, et al. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: Efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med Genomics. 2008;1(1):50. doi:10.1186/1755-8794-1-50
  6. Schaefer GB, Mendelsohn NJ; Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399−407. doi:10.1038/gim.2013.32
  7. Steinman KJ, Spence SJ, Ramocki MB, et al; Simons VIP Consortium. 16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort. Am J Med Genet Part A. 2016;170(11):2943−2955. doi:10.1002/ajmg.a.37820
  8. Boggula VR, Shukla A, Danda S, et al. Clinical utility of multiplex ligation-dependent probe amplification technique in identification of aetiology of unexplained mental retardation: A study in 203 Indian patients. Indian J Med Res. 2014;139(1):66−75.
  9. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. 10th revision, 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
  10. International Standards for Cytogenomic Arrays (ISCA) Consortium – Submitter: ClinVar. Accessed May 23, 2019.
  11. Shin S, Yu N, Choi JR, Jeong S, Lee K-A. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder. Ann Lab Med. 2015;35(5):510−518. doi:10.3343/alm.2015.35.5.510
  12. Bennett JA, Germani T, Haqq AM, Zwaigenbaum L. Autism spectrum disorder in Prader–Willi syndrome: A systematic review. Am J Med Genet Part A. 2015;167(12):2936−2944. doi:10.1002/ajmg.a.37286
  13. Gillentine MA, Schaaf CP. The human clinical phenotypes of altered CHRNA7 copy number. Biochem Pharmacol. 2015;97(4):352–362. doi:10.1016/j.bcp.2015.06.012
  14. Papandreou A, McTague A, Trump N, et al. GABRB3 mutations: A new and emerging cause of early infantile epileptic encephalopathy. Dev Med Child Neurol. 2016;58(4):416−420. doi:10.1111/dmcn.12976
  15. Moreira DP, Griesi-Oliveira K, Bossolani-Martins AL, et al. Investigation of 15q11-q13, 16p11.2 and 22q13 CNVs in autism spectrum disorder Brazilian individuals with and without epilepsy. PLoS One. 2014;9(9):e107705. doi:10.1371/journal.pone.0107705
  16. Stewart LR, Hall AL, Kang S-HL, Shaw CA, Beaudet AL. High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy. BMC Med Genet. 2011;12(1):154. doi:10.1186/1471-2350-12-154
  17. Bacchelli E, Battaglia A, Cameli C, et al. Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility. Am J Med Genet Part A. 2015;167(4):715−723. doi:10.1002/ajmg.a.36847
  18. Peixoto S, Melo JB, Ferrão J, et al. MLPA analysis in a cohort of patients with autism. Mol Cytogenet. 2017;10:2. doi:10.1186/s13039-017-0302-z